Company · CIK 0001806540
Lycia Therapeutics, Inc.
Exchange
—
Entity type
other
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- S-1IPO registration0001628280-26-064973 · 17.1 MBSEC(opens sec.gov)
Insiders
No insiders on record.
Tickers
No tickers on record.
Addresses
business
400 EAST JAMIE COURT, SUITE 200
SOUTH SAN FRANCISCO, CA, 94080
mailing
400 EAST JAMIE COURT, SUITE 200
SOUTH SAN FRANCISCO, CA, 94080
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies